Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 35, 2022 - Issue 9
Submit an article Journal homepage
126
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Impact of cell-free fetal DNA on early invasive prenatal diagnosis at a Chinese reference maternal medicine center

Li-Li Xua Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center affiliated to Guangzhou Medical University, Guangzhou, ChinaView further author information
,
Dan Yangb Capitalbio Genomics Co., LtdView further author information
,
Li Zhena Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center affiliated to Guangzhou Medical University, Guangzhou, ChinaView further author information
,
Min Pana Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center affiliated to Guangzhou Medical University, Guangzhou, ChinaView further author information
,
Jin Hana Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center affiliated to Guangzhou Medical University, Guangzhou, ChinaView further author information
,
Xin Yanga Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center affiliated to Guangzhou Medical University, Guangzhou, ChinaView further author information
&
Dong-Zhi Lia Prenatal Diagnostic Center, Guangzhou Women and Children’s Medical Center affiliated to Guangzhou Medical University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1764-1768 | Received 04 Feb 2020, Accepted 11 May 2020, Published online: 24 May 2020

References

  • Vogel I, Tabor A, Ekelund C, et al. Population-based screening for trisomies and atypical chromosomal abnormalities: improving efficacy using the combined first trimester screening algorithm as well as individual risk parameters. Fetal Diagn Ther. 2019;45(6):424–429.
  • Gil MM, Accurti V, Santacruz B, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–314.
  • Xu L, Huang H, Lin N, et al. Non-invasive cell-free fetal DNA testing: a multicenter follow-up study of 31515 singleton pregnancies in southeastern China. Ultrasound Obstet Gynecol. 2020;55(2):242–247.
  • Salomon LJ, Sotiriadis A, Wulff CB, et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54(4):442–451.
  • Chan YM, Leung TY, Chan OK, et al. Patient’s choice between a non-invasive prenatal test and invasive prenatal diagnosis based on test accuracy. Fetal Diagn Ther. 2014;35(3):193–198.
  • Martínez-Payo C, Bada-Bosch I, Martínez-Moya M, et al. Clinical results after the implementation of cell-free fetal DNA detection in maternal plasma. J Obstet Gynaecol Res. 2018;44(8):1369–1376.
  • Herraiz I, Villalba A, Ajuria E, et al. Impact of cell-free fetal DNA on invasive prenatal diagnostic tests in a real-world public setting. J Perinat Med. 2019;47(5):547–552.
  • Bayón JC, Orruño E, Portillo MI, et al. The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis. Cost Eff Resour Alloc. 2019;17:6.
  • Miranda J, Paz Y Miño F, Borobio V, et al. Can cell-free DNA testing be used in pregnancies with increased nuchal translucency? Ultrasound Obstet Gynecol. 2020;55(5):645–651.
  • Grossman TB, Bodenlos KL, Chasen ST. Abnormal nuchal translucency: residual risk with normal cell-free DNA screening. J Matern Fetal Neonatal Med. 2019;1–6. DOI:https://doi.org/10.1080/14767058.2019.1568405 [Online ahead of print]
  • Jiang F, Chen GL, Li J, et al. Pre gestational thalassemia screening in Mainland China: the first two years of a preventive program. Hemoglobin. 2017;41(4–6):248–253.
  • Larsen D, Ma J, Strassberg M, et al. The uptake of pan-ethnic expanded carrier screening is higher when offered during preconception or early prenatal genetic counseling. Prenat Diagn. 2019;39(4):319–323.
  • Schuurmans J, Birnie E, Ranchor AV, et al. GP-provided couple-based expanded preconception carrier screening in the Dutch general population: who accepts the test-offer and why? Eur J Hum Genet. 2019;27(5):691–700.
  • Brandenburg H, van der Zwan L, Jahoda MG, et al. Prenatal diagnosis in advanced maternal age. Amniocentesis or CVS, a patient’s choice or lack of information? Prenat Diagn. 1991;11(9):685–690.
  • Stern S, Hacohen N, Meiner V, et al. Universal chromosomal microarray analysis reveals high proportion of copy number variants in low risk pregnancies. Ultrasound Obstet Gynecol. 2020. DOI:https://doi.org/10.1002/uog.22026 [Online ahead of print]
  • Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies. Genet Med. 2019;21:2462–2467.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.